# CART19 in Adult Patients With Minimal Residual Disease During Upfront Treatment for ALL

> **NCT02935543** · PHASE2 · TERMINATED · sponsor: **University of Pennsylvania** · enrollment: 1 (actual)

## Conditions studied

- Leukemia, Acute Lymphoblastic

## Interventions

- **BIOLOGICAL:** CART 19

## Key facts

- **NCT ID:** NCT02935543
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-10
- **Primary completion:** 2018-12-12
- **Final completion:** 2018-12-12
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Study is terminated because of administrative reasons.
- **Last updated:** 2023-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02935543

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02935543, "CART19 in Adult Patients With Minimal Residual Disease During Upfront Treatment for ALL". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02935543. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*